US Stock MarketDetailed Quotes

AKRO Akero Therapeutics

Watchlist
  • 42.720
  • -0.860-1.97%
Close Mar 28 16:00 ET
  • 42.720
  • 0.0000.00%
Post 16:20 ET
3.40BMarket Cap-11.39P/E (TTM)

Akero Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
65.11%285.42M
26.11%78.03M
75.27%81.7M
84.52%65.74M
108.51%59.95M
50.12%172.87M
143.40%61.87M
29.16%46.62M
29.12%35.63M
10.37%28.75M
Selling and administrative expenses
22.06%37.93M
2.96%8.73M
18.67%9.47M
36.30%10.42M
33.56%9.3M
4.02%31.07M
19.45%8.48M
-27.47%7.98M
22.68%7.64M
25.81%6.97M
-General and administrative expense
22.06%37.93M
2.96%8.73M
18.67%9.47M
36.30%10.42M
33.56%9.3M
4.02%31.07M
19.45%8.48M
-27.47%7.98M
22.68%7.64M
25.81%6.97M
Research and development costs
74.54%247.5M
29.78%69.29M
86.96%72.23M
97.68%55.32M
132.48%50.65M
66.27%141.8M
191.44%53.39M
54.00%38.63M
31.00%27.99M
6.21%21.79M
Operating profit
-65.11%-285.42M
-26.11%-78.03M
-75.27%-81.7M
-84.52%-65.74M
-108.51%-59.95M
-50.12%-172.87M
-143.40%-61.87M
-29.16%-46.62M
-29.12%-35.63M
-10.37%-28.75M
Net non-operating interest income expense
58.04%33.36M
19.65%8M
29.36%9M
114.56%9.75M
126.21%6.61M
575.98%21.11M
91.06%6.69M
2,246.91%6.96M
8,677.36%4.55M
13,181.82%2.92M
Non-operating interest income
57.09%38.03M
21.32%9.2M
30.60%10.24M
103.31%10.99M
124.95%7.6M
526.88%24.21M
--7.58M
--7.84M
--5.4M
15,259.09%3.38M
Non-operating interest expense
50.63%4.67M
33.78%1.2M
40.32%1.25M
43.64%1.23M
116.85%991K
319.35%3.1M
147.79%897K
174.07%888K
1,516.98%857K
--457K
Other net income (expense)
Income before tax
-66.09%-252.06M
-26.89%-70.02M
-83.33%-72.71M
-80.12%-55.99M
-106.51%-53.34M
-35.46%-151.76M
-139.33%-55.19M
-11.58%-39.66M
-13.43%-31.08M
0.76%-25.83M
Income tax
Net income
-66.09%-252.06M
-26.89%-70.02M
-83.33%-72.71M
-80.12%-55.99M
-106.51%-53.34M
-35.46%-151.76M
-139.33%-55.19M
-11.58%-39.66M
-13.43%-31.08M
0.76%-25.83M
Net income continuous Operations
-66.09%-252.06M
-26.89%-70.02M
-83.33%-72.71M
-80.12%-55.99M
-106.51%-53.34M
-35.46%-151.76M
-139.33%-55.19M
-11.58%-39.66M
-13.43%-31.08M
0.76%-25.83M
Minority interest income
Net income attributable to the parent company
-66.09%-252.06M
-26.89%-70.02M
-83.33%-72.71M
-80.12%-55.99M
-106.51%-53.34M
-35.46%-151.76M
-139.33%-55.19M
-11.58%-39.66M
-13.43%-31.08M
0.76%-25.83M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-66.09%-252.06M
-26.89%-70.02M
-83.33%-72.71M
-80.12%-55.99M
-106.51%-53.34M
-35.46%-151.76M
-139.33%-55.19M
-11.58%-39.66M
-13.43%-31.08M
0.76%-25.83M
Basic earnings per share
-29.76%-3.75
2.94%-0.99
-47.89%-1.05
-35.00%-0.81
-63.64%-0.9
-0.70%-2.89
-108.16%-1.02
22.83%-0.71
22.08%-0.6
25.68%-0.55
Diluted earnings per share
-29.76%-3.75
2.94%-0.99
-47.89%-1.05
-35.00%-0.81
-63.64%-0.9
-0.70%-2.89
-108.16%-1.02
22.83%-0.71
22.08%-0.6
25.68%-0.55
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 65.11%285.42M26.11%78.03M75.27%81.7M84.52%65.74M108.51%59.95M50.12%172.87M143.40%61.87M29.16%46.62M29.12%35.63M10.37%28.75M
Selling and administrative expenses 22.06%37.93M2.96%8.73M18.67%9.47M36.30%10.42M33.56%9.3M4.02%31.07M19.45%8.48M-27.47%7.98M22.68%7.64M25.81%6.97M
-General and administrative expense 22.06%37.93M2.96%8.73M18.67%9.47M36.30%10.42M33.56%9.3M4.02%31.07M19.45%8.48M-27.47%7.98M22.68%7.64M25.81%6.97M
Research and development costs 74.54%247.5M29.78%69.29M86.96%72.23M97.68%55.32M132.48%50.65M66.27%141.8M191.44%53.39M54.00%38.63M31.00%27.99M6.21%21.79M
Operating profit -65.11%-285.42M-26.11%-78.03M-75.27%-81.7M-84.52%-65.74M-108.51%-59.95M-50.12%-172.87M-143.40%-61.87M-29.16%-46.62M-29.12%-35.63M-10.37%-28.75M
Net non-operating interest income expense 58.04%33.36M19.65%8M29.36%9M114.56%9.75M126.21%6.61M575.98%21.11M91.06%6.69M2,246.91%6.96M8,677.36%4.55M13,181.82%2.92M
Non-operating interest income 57.09%38.03M21.32%9.2M30.60%10.24M103.31%10.99M124.95%7.6M526.88%24.21M--7.58M--7.84M--5.4M15,259.09%3.38M
Non-operating interest expense 50.63%4.67M33.78%1.2M40.32%1.25M43.64%1.23M116.85%991K319.35%3.1M147.79%897K174.07%888K1,516.98%857K--457K
Other net income (expense)
Income before tax -66.09%-252.06M-26.89%-70.02M-83.33%-72.71M-80.12%-55.99M-106.51%-53.34M-35.46%-151.76M-139.33%-55.19M-11.58%-39.66M-13.43%-31.08M0.76%-25.83M
Income tax
Net income -66.09%-252.06M-26.89%-70.02M-83.33%-72.71M-80.12%-55.99M-106.51%-53.34M-35.46%-151.76M-139.33%-55.19M-11.58%-39.66M-13.43%-31.08M0.76%-25.83M
Net income continuous Operations -66.09%-252.06M-26.89%-70.02M-83.33%-72.71M-80.12%-55.99M-106.51%-53.34M-35.46%-151.76M-139.33%-55.19M-11.58%-39.66M-13.43%-31.08M0.76%-25.83M
Minority interest income
Net income attributable to the parent company -66.09%-252.06M-26.89%-70.02M-83.33%-72.71M-80.12%-55.99M-106.51%-53.34M-35.46%-151.76M-139.33%-55.19M-11.58%-39.66M-13.43%-31.08M0.76%-25.83M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -66.09%-252.06M-26.89%-70.02M-83.33%-72.71M-80.12%-55.99M-106.51%-53.34M-35.46%-151.76M-139.33%-55.19M-11.58%-39.66M-13.43%-31.08M0.76%-25.83M
Basic earnings per share -29.76%-3.752.94%-0.99-47.89%-1.05-35.00%-0.81-63.64%-0.9-0.70%-2.89-108.16%-1.0222.83%-0.7122.08%-0.625.68%-0.55
Diluted earnings per share -29.76%-3.752.94%-0.99-47.89%-1.05-35.00%-0.81-63.64%-0.9-0.70%-2.89-108.16%-1.0222.83%-0.7122.08%-0.625.68%-0.55
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More